Production Qualilty Control And Clinical Applications Of Radiosynovectomy Agents

Please use this identifier to cite or link to this item: http://elibrary.nnra.gov.ng/jspui/handle/123456789/684

Full metadata record

DC Field	Value	Language
dc.contributor.author	IAEA	-
dc.date.accessioned	2021-06-30T10:15:36Z	-
dc.date.available	2021-06-30T10:15:36Z	-
dc.date.issued	2021	-
dc.identifier.uri	http://elibrary.nnra.gov.ng/jspui/handle/123456789/684	-
dc.description	Therapeutic radiopharmaceuticals play a major role in today’s nuclear medicine, especially in the treatment of cancer. They have long been applied in ‘radiation synovectomy’, or, more briefly, ‘radiosynovectomy’ (RSV). In recent decades, the production and quality control of radiopharmaceuticals for use in RSV has moved from simple 32P colloids to recently developed matrixes labelled with short and medium range beta emitters. RSV is a well established technique with growing applications worldwide. However, the lack of generic and peer reviewed production, quality control and clinical application guidelines and recommendations is a major concern for their application in human patients.	en_US
dc.language.iso	en	en_US
dc.publisher	NNRA Library	en_US
dc.relation.ispartofseries	NO-3;	-
dc.subject	Radiopharmaceuticals	en_US
dc.subject	Synovectomy	en_US
dc.subject	Nuclear medicine.	en_US
dc.subject	Radioisotopes — Therapeutic use	en_US
dc.title	Production Qualilty Control And Clinical Applications Of Radiosynovectomy Agents	en_US
dc.type	Book	en_US
Appears in Collections:	Human Health

Files in This Item:

File	Description	Size	Format
PRODUCTION, QUALITY CONTROL AND CLINICAL APPLICATIONS OF RADIOSYNOVECTOMY AGENTS.pdf		5.62 MB	Adobe PDF	View/Open

NNRA e-Library